EPISODE · Apr 17, 2026 · 21 MIN
#54. Companion Diagnostic Biomarkers
from Drug Discovery AI Talk · host Dr. Jake Chen
In this episode, we outline the critical role of biomarkers and companion diagnostics (CDx) in advancing personalized medicine and streamlining drug discovery. It details how germline genetic variations help prevent adverse reactions, while somatic mutations and multi-gene expression panels allow for precise targeting of therapies, particularly within oncology. The episode emphasizes that while thousands of candidate markers exist, only those deemed essential for the safe and effective use of a specific drug achieve regulatory status as a companion diagnostic. By integrating multi-omics technologies—including proteomics and metabolomics—and AI, researchers can create more comprehensive profiles of disease biology. Ultimately, the co-development of drugs and their diagnostic counterparts is shown to increase clinical trial success rates, reduce patient toxicity, and accelerate the delivery of tailored treatments to the market. Produced by Dr. Jake Chen.
NOW PLAYING
#54. Companion Diagnostic Biomarkers
No transcript for this episode yet
Similar Episodes
Mar 31, 2026 ·54m
Mar 27, 2026 ·14m
Mar 24, 2026 ·42m
Mar 20, 2026 ·42m
Mar 17, 2026 ·41m
Mar 13, 2026 ·44m